Lyell Immunopharma Inc

NASDAQ:LYEL   3:59:54 PM EDT
13.25
-1.26 (-8.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.17B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.51 Million
Adjusted EPS-$0.52
See more estimates
10-Day MA$15.21
50-Day MA$15.45
200-Day MAN/A
See more pivots

Lyell Immunopharma Inc Stock, NASDAQ:LYEL

400 East Jamie Court, Suite 301, South San Francisco, California 94080
United States of America
Phone: +1.650.695.0677
Number of Employees:

Description

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.